Cardinal Capital Management Inc (North Carolina)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.7M | Sell |
|
|||||
|
2025
Q2 | $1.65M | Buy |
|
|||||
|
2025
Q1 | $1.61M | Buy |
|
|||||
|
2024
Q4 | $1.94M | Sell |
|
|||||
|
2024
Q3 | $2.07M | Buy |
|
|||||
|
2024
Q2 | $2.11M | Buy |
|
|||||
|
2024
Q1 | $2.66M | Buy |
|
|||||
|
2023
Q4 | $2M | Buy |
|
|||||
|
2023
Q3 | $1.65M | Buy |
|
|||||
|
2023
Q2 | $1.73M | Buy |
|
|||||
|
2023
Q1 | $1.64M | Buy |
|
|||||
|
2022
Q4 | $1.76M | Buy |
|
|||||
|
2022
Q3 | $1.56M | Buy |
|
|||||
|
2022
Q2 | $1.65M | Buy |
|
|||||
|
2022
Q1 | $2.18M | Buy |
|
|||||
|
2021
Q4 | $2.83M | Sell |
|
|||||
|
2021
Q3 | $3.12M | Buy |
|
|||||
|
2021
Q2 | $2.79M | Sell |
|
|||||
|
2021
Q1 | $2.21M | Buy |
|
|||||
|
2020
Q4 | $1.9M | Buy |
|
|||||
|
2020
Q3 | $1.71M | Buy |
|
|||||
|
2020
Q2 | $1.29M | Buy |
|
|||||
|
2020
Q1 | $897K | Sell |
|
|||||
|
2019
Q4 | $1.22M | Sell |
|
|||||
|
2019
Q3 | $1.07M | Sell |
|
|||||
|
2019
Q2 | $1.17M | Sell |
|
|||||
|
2019
Q1 | $1.23M | Sell |
|
|||||
|
2018
Q4 | $957K | Buy |
|
|||||
|
2018
Q3 | $1.12M | Buy |
|
|||||
|
2018
Q2 | $931K | Buy |
|
|||||
|
2018
Q1 | $880K | Sell |
|
|||||
|
2017
Q4 | $912K | Sell |
|
|||||
|
2017
Q3 | $912K | Buy |
|
|||||
|
2017
Q2 | $799K | Buy |
|
|||||
|
2017
Q1 | $633K | Buy |
|
|||||
|
2016
Q4 | $530K | Buy |
|
|||||
|
2016
Q3 | $505K | Buy |
|
|||||
|
2016
Q2 | $465K | Buy |
|
|||||
|
2016
Q1 | $408K | Buy |
|
|||||
|
2015
Q4 | $405K | Buy |
|
|||||
|
2015
Q3 | $309K | Buy |
|
|||||
|
2015
Q2 | $306K | Buy |
|
|||||
|
2015
Q1 | $291K | Buy |
|
|||||
|
2014
Q4 | $202K | Buy |
|